tofacitinib model Search Results


tofacitinib  (Galapagos NV)
90
Galapagos NV tofacitinib
In vitro Isoform Selectivity of Available JAK Inhibitors for <t> IBD </t>
Tofacitinib, supplied by Galapagos NV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tofacitinib+model/pmc10885424-67-12-17?v=Galapagos+NV
Average 90 stars, based on 1 article reviews
tofacitinib - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


In vitro Isoform Selectivity of Available JAK Inhibitors for IBD

Journal: Gastroenterology & Hepatology

Article Title: Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?

doi:

Figure Lengend Snippet: In vitro Isoform Selectivity of Available JAK Inhibitors for IBD

Article Snippet: 6 , 7 For IBD, 3 jakinibs have been approved for moderate-to-severe IBD: tofacitinib and filgotinib (Jyseleca, Galapagos NV) for UC and more recently upadacitinib (Rinvoq, AbbVie) for both UC and CD.

Techniques: In Vitro, Enzymatic Assay

Summary of Pivotal Trials for Licensed JAK Inhibitors in Inflammatory Bowel Disease

Journal: Gastroenterology & Hepatology

Article Title: Are All Janus Kinase Inhibitors for Inflammatory Bowel Disease the Same?

doi:

Figure Lengend Snippet: Summary of Pivotal Trials for Licensed JAK Inhibitors in Inflammatory Bowel Disease

Article Snippet: 6 , 7 For IBD, 3 jakinibs have been approved for moderate-to-severe IBD: tofacitinib and filgotinib (Jyseleca, Galapagos NV) for UC and more recently upadacitinib (Rinvoq, AbbVie) for both UC and CD.

Techniques: Selection